Cargando…
DNA Methylation as a Therapeutic and Diagnostic Target in Major Depressive Disorder
Autor principal: | Lax, Elad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006940/ https://www.ncbi.nlm.nih.gov/pubmed/35431832 http://dx.doi.org/10.3389/fnbeh.2022.759052 |
Ejemplares similares
-
Computerized Working Memory Training in Remission From Major Depressive Disorder: Effects on Emotional Working Memory, Processing Speed, Executive Functions, and Associations With Symptoms
por: Ronold, Eivind Haga, et al.
Publicado: (2022) -
White Matter Microstructure Alterations Associated With Paroxetine Treatment Response in Major Depression
por: Vieira, Rita, et al.
Publicado: (2021) -
Blood Brain-Derived Neurotrophic Factor (BDNF) and Major Depression: Do We Have a Translational Perspective?
por: Arosio, Beatrice, et al.
Publicado: (2021) -
Changes in Cortisol but Not in Brain-Derived Neurotrophic Factor Modulate the Association Between Sleep Disturbances and Major Depression
por: Santiago, Giuliana Travassos Pires, et al.
Publicado: (2020) -
Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhou, Jiaqi, et al.
Publicado: (2021)